ClinicalTrials.gg
Drug

Abiraterone clinical trials

Also written JNJ-212082 and CB 7598.

Includes 127 studies of Abiraterone Acetate.

studies test it
164
open now
25
in phase 3
15
first study started
2005
Related medicines add 3 studies

Counted the way a researcher would: Abiraterone with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses abiraterone is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the abiraterone studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
28 Apr 2011 · ZYTIGA · NDA 202379 (FDA, Drugs@FDA; as Abiraterone Acetate)
European Union
5 Sept 2011 · Zytiga · EMEA/H/C/002321 (EMA; as Abiraterone Acetate)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Abiraterone
28
Zytiga
10
Yonsa
2
Abiraterone Oral Tablet
2

Development codes

JNJ-212082
2
CB 7598
2
CB7630
1

In one entry with another drug

Given together, or one or the other

Abiraterone + prednisone
2

Studies by the year they started

164 studies that test it; most in 2012 (16)

Studies that test abiraterone, by start year
YearStudies
20052
20062
20074
20082
20096
20104
20119
201216
201313
201412
20155
201610
20179
20186
20199
202014
202111
20225
20236
20247
20258
20264

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
48
Phase 2
107
Phase 3
15
Phase 4
4
No phase
3

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 61 · Other 103

Janssen Research & Development, LLC (26) · Cougar Biotechnology, Inc. (9) · M.D. Anderson Cancer Center (6) · University of Washington (4) · Memorial Sloan Kettering Cancer Center (3) · UNICANCER (3) · Dana-Farber Cancer Institute (3) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (3)

Often tested with

Tested in the same studies.

Prednisone (36) · Enzalutamide (18) · Apalutamide (16) · Niraparib (7) · Leuprolide (6) · Docetaxel (6) · Prednisolone (6) · Cabazitaxel (6)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 7 phase 3 studies under way

Abiraterone is the comparator. A study of two new drugs counts under both.

Reaching primary completion within a year · 11, 1 in phase 3

Studies that test abiraterone, phase 3 first.

Studies

Open first, then newest update. How each study uses abiraterone is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 164

See all 164 studies that test abiraterone →

Given beside what is tested · 120 — abiraterone is usual care or a partner of the new treatment

Showing 20 of 120.

As the comparator · 22 — what is tested is compared with abiraterone

Showing 20 of 22.

Codes

What other systems call abiraterone · ClinicalTrials.gg INT003801

  • MeSH (NLM) C089740abirateroneConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) G819A456D0ABIRATERONEConfirmed FDA, NLM, Wikidata
  • RxNorm 1100072Confirmed FDA, Wikidata
  • Wikidata Q321431abirateroneConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C77333AbirateroneOne source FDA
  • DrugBank DB05812One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.